ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSE ROCAMORA MD

Cardiovascular Disease

45,055

$2.14M

1473
1174 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

21%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $67

HENRY YEE MD

Cardiovascular Disease

37,321

$3.8M

1370
1278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 28%

$102
Average prescription price

Avg: $67

MOHAMED KHAN M.D.

Cardiovascular Disease

13,758

$958K

1295
1043 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$70
Average prescription price

Avg: $67

NGAI NGUYEN MD

Cardiovascular Disease

25,657

$3.37M

1277
1207 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 28%

$131
Average prescription price

Avg: $67

GARY REZNIK MD

Cardiovascular Disease

46,107

$4.67M

1260
1234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 28%

$101
Average prescription price

Avg: $67

RAMA THUMATI MD

Cardiovascular Disease

17,733

$453K

1253
1161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 28%

$26
Average prescription price

Avg: $67

KEVIN BORAN M.D.

Cardiovascular Disease

15,913

$1.08M

1251
1109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $67

STANLEY LAU M.D.

Cardiovascular Disease

11,873

$515K

1222
1157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 28%

$43
Average prescription price

Avg: $67

GUSTIN HO M.D.

Cardiovascular Disease

21,804

$1.49M

1208
1174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $67

MICHAEL NORMAN DO

Cardiovascular Disease

21,812

$1.15M

1157
938 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $67

RAJIV PUNJYA M.D.

Cardiovascular Disease

14,041

$952K

1133
964 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 28%

$68
Average prescription price

Avg: $67

MEHRAN MOUSSAVIAN DO

Cardiovascular Disease

12,856

$548K

1105
959 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 28%

$43
Average prescription price

Avg: $67

GARY CONRAD M.D.

Cardiovascular Disease

8,794

$608K

1065
1028 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $67

BENJAMIN POTKIN M.D.

Cardiovascular Disease

14,966

$890K

1064
934 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 28%

$59
Average prescription price

Avg: $67

TAO DUONG M.D.

Cardiovascular Disease

21,731

$1.67M

1063
997 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 28%

$77
Average prescription price

Avg: $67

MICHAEL DAM MD

Cardiovascular Disease

6,479

$150K

1051
978 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

6%
prescriptions for brand name drugs

Avg: 28%

$23
Average prescription price

Avg: $67

OSCAR ZAMBRANO M.D.

Cardiovascular Disease

22,733

$918K

1008
870 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$40
Average prescription price

Avg: $67

STEVE SEEKOOK PARK M.D.

Cardiovascular Disease

13,244

$795K

1006
964 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 28%

$60
Average prescription price

Avg: $67

GHOLAMREZA VAFADOUSTE MD

Cardiovascular Disease

9,653

$340K

975
837 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 28%

$35
Average prescription price

Avg: $67

CHIN SHUN SHIH M.D.

Cardiovascular Disease

19,572

$1.19M

937
903 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $67

DAREL BENVENUTI MD

Cardiovascular Disease

9,194

$845K

929
886 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 28%

$92
Average prescription price

Avg: $67

TRI NGUYEN M.D.

Cardiovascular Disease

12,772

$971K

919
839 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$76
Average prescription price

Avg: $67

ROHIT SUNDRANI M.D.

Cardiovascular Disease

12,038

$829K

918
783 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $67

JENCHEN YANG M.D., PH.D

Cardiovascular Disease

18,487

$1.95M

916
887 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 28%

$105
Average prescription price

Avg: $67

MICHAEL GEN M.D.

Cardiovascular Disease

11,862

$847K

887
764 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$71
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank